NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.60
Delayed Data
As of 3:34pm ET
 +0.06 / +11.11%
Today’s Change
0.42
Today|||52-Week Range
1.38
-4.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues9.8M11.0M6.9M3.5M
 
 
 
 
 
Cost of Goods Sold0.00--0.00162.0K
 
 
Depreciation And Amortization427.0K425.0K341.0K314.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.3M--6.6M3.0M
 
 
 
 
General Expenses13.8M14.9M14.9M18.5M
 
 
 
 
 
Research And Development8.6M9.9M9.3M12.5M
 
 
 
 
 
Total Operating Expenses14.3M15.3M15.3M19.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-4.3M-8.3M-15.5M
 
 
 
 
 
Extraordinary Credit0.000.001.4M--
 
 
Extraordinary Charge0.00-732.0K0.00-555.0K
 
 
 
Other Expenses258.0K-30.0K-155.0K1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.3M-5.1M-7.0M-16.0M
 
 
 
 
 
Income Taxes-50.0K-2.0K-2.0K-2.0K
 
 
 
 
 
Net Income-4.3M-5.1M-7.0M-16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.3M25.8M29.4M38.2M
 
 
 
 
 
Shares To Calculate EPS Diluted23.3M25.8M29.4M38.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.20-$0.24-$0.42
 
 
 
 
 
EPS Diluted-$0.18-$0.20-$0.24-$0.42
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account